IL6 and breast cancer: A recent study has shown that high IL-6 expression was an independent prognostic marker in terms of longer overall survival and DFS in BC [33], however the difference in sample size (n = 108 vs. 1191 in the current study) and the prognostic factors included in Cox regression analysis may explain the differences between the Fernandez-Garcia et al. paper [33] and current results.